0001958244-24-002794.txt : 20240611
0001958244-24-002794.hdr.sgml : 20240611
20240611171635
ACCESSION NUMBER: 0001958244-24-002794
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 241036747
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUSSALLEM MICHAEL A
CENTRAL INDEX KEY: 0001204551
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORP
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
144
1
primary_doc.xml
144
0001204551
XXXXXXXX
LIVE
0001099800
Edwards Lifesciences Corporation
001-15525
1 Edwards Way
Irvine
CA
92614
1-949-250-2500
Michael A. Mussallem
Other: Former CEO
Common
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
92300
8030100
601300000
06/11/2024
NYSE
Common
05/17/2018
Acquired as compensation -- Stock Options
Issuer
N
92300
05/17/2018
Compensation -- Cashless exercise / same-day sale
N
Mussallem Living Trust dtd 03/07/2005
1 Edwards Way
Irvine
CA
92614
Common
05/02/2024
29350
2487940.21
Mussallem Living Trust dtd 03/07/2005
1 Edwards Way
Irvine
CA
92614
Common
04/04/2024
29350
2712421.34
The sales of shares set forth herein are made in connection with a selling plan dated 2/12/2024, that is intended to comply with Rule 10b5-1(c). Shares to be sold by Mussallem Living Trust dtd 03/07/2005.
06/11/2024
02/12/2024
Goldman Sachs & Co. LLC on behalf of Michael A. Mussallem